Characterisation of three novel CYP11B1 mutations in classic and non-classic 11β-hydroxylase deficiency - PubMed (original) (raw)
. 2014 Apr 10;170(5):697-706.
doi: 10.1530/EJE-13-0737. Print 2014 May.
Affiliations
- PMID: 24536089
- DOI: 10.1530/EJE-13-0737
Characterisation of three novel CYP11B1 mutations in classic and non-classic 11β-hydroxylase deficiency
Seher Polat et al. Eur J Endocrinol. 2014.
Abstract
Background: Congenital adrenal hyperplasia (CAH) is one of the most common autosomal recessive inherited endocrine diseases. Steroid 11β-hydroxylase (P450c11) deficiency (11OHD) is the second most common form of CAH.
Aim: The aim of the study was to study the functional consequences of three novel CYP11B1 gene mutations (p.His125Thrfs*8, p.Leu463_Leu464dup and p.Ser150Leu) detected in patients suffering from 11OHD and to correlate this data with the clinical phenotype.
Methods: Functional analyses were done by using a HEK293 cell in vitro expression system comparing WT with mutant P450c11 activity. Mutant proteins were examined in silico to study their effect on the three-dimensional structure of the protein.
Results: Two mutations (p.His125Thrfs*8 and p.Leu463_Leu464dup) detected in patients with classic 11OHD showed a complete loss of P450c11 activity. The mutation (p.Ser150Leu) detected in a patient with non-classic 11OHD showed partial functional impairment with 19% of WT activity.
Conclusion: Functional mutation analysis enables the correlation of novel CYP11B1 mutations to the classic and non-classic 11OHD phenotype respectively. Mutations causing a non-classic phenotype show typically partial impairment due to reduced maximum reaction velocity comparable with non-classic mutations in 21-hydroxylase deficiency. The increasing number of mutations associated with non-classic 11OHD illustrate that this disease should be considered as diagnosis in patients with otherwise unexplained hyperandrogenism.
Similar articles
- Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.
Parajes S, Loidi L, Reisch N, Dhir V, Rose IT, Hampel R, Quinkler M, Conway GS, Castro-Feijóo L, Araujo-Vilar D, Pombo M, Dominguez F, Williams EL, Cole TR, Kirk JM, Kaminsky E, Rumsby G, Arlt W, Krone N. Parajes S, et al. J Clin Endocrinol Metab. 2010 Feb;95(2):779-88. doi: 10.1210/jc.2009-0651. Epub 2010 Jan 20. J Clin Endocrinol Metab. 2010. PMID: 20089618 Free PMC article. - Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations.
Menabò S, Polat S, Baldazzi L, Kulle AE, Holterhus PM, Grötzinger J, Fanelli F, Balsamo A, Riepe FG. Menabò S, et al. Eur J Hum Genet. 2014 May;22(5):610-6. doi: 10.1038/ejhg.2013.197. Epub 2013 Sep 11. Eur J Hum Genet. 2014. PMID: 24022297 Free PMC article. - The combination of a novel 2 bp deletion mutation and p.D63H in CYP11B1 cause congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency.
Long Y, Han S, Zhang X, Zhang X, Chen T, Gao Y, Tian H. Long Y, et al. Endocr J. 2016;63(3):301-10. doi: 10.1507/endocrj.EJ15-0433. Epub 2016 Jan 22. Endocr J. 2016. PMID: 26806323 - Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.
Peter M. Peter M. Semin Reprod Med. 2002 Aug;20(3):249-54. doi: 10.1055/s-2002-35389. Semin Reprod Med. 2002. PMID: 12428205 Review. - Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
Nimkarn S, New MI. Nimkarn S, et al. Trends Endocrinol Metab. 2008 Apr;19(3):96-9. doi: 10.1016/j.tem.2008.01.002. Epub 2008 Feb 21. Trends Endocrinol Metab. 2008. PMID: 18294861 Review.
Cited by
- Genetic background of neonatal hypokalemia.
Fang C, Zhou W. Fang C, et al. Pediatr Nephrol. 2024 Sep 16. doi: 10.1007/s00467-024-06492-5. Online ahead of print. Pediatr Nephrol. 2024. PMID: 39283520 Review. - Non-classical 11β-hydroxylase deficiency caused by a novel heterozygous mutation: a case report and review of the literature.
Tang S, Xu W, Xuan M, Liu Q, Li Y, Kong D, Yang H, Liu Y, Xue Y. Tang S, et al. Endocrine. 2024 Jun;84(3):1193-1205. doi: 10.1007/s12020-024-03746-y. Epub 2024 Feb 27. Endocrine. 2024. PMID: 38411873 Review. - Unexpectedly high mutation rate of cyp11b1 compared to cyp21a2 in randomly-selected turkish women: a large screening study.
Polat S, Karaburgu S, Unluhizarci K, Dundar M, Ozkul Y, Arslan YK, Karaca Z, Kelestimur F. Polat S, et al. J Endocrinol Invest. 2023 Nov;46(11):2367-2377. doi: 10.1007/s40618-023-02093-5. Epub 2023 Apr 13. J Endocrinol Invest. 2023. PMID: 37055708 - Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.
Barbot M, Mazzeo P, Lazzara M, Ceccato F, Scaroni C. Barbot M, et al. Front Endocrinol (Lausanne). 2022 Aug 1;13:934675. doi: 10.3389/fendo.2022.934675. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35979433 Free PMC article. Review. - Detection of Small CYP11B1 Deletions and One Founder Chimeric CYP11B2/CYP11B1 Gene in 11β-Hydroxylase Deficiency.
Xie H, Yin H, Ye X, Liu Y, Liu N, Zhang Y, Chen X, Chen X. Xie H, et al. Front Endocrinol (Lausanne). 2022 May 24;13:882863. doi: 10.3389/fendo.2022.882863. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35685215 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases